… The clinical course of idiopathic pulmonary fibrosis (IPF) is characterized by a gradual
decline in pulmonary function, which eventually results in mortality [1]. Although the prognosis of …

… that there are links between weight loss and fibrotic processes, we have not … weight loss
as measures of nutritional status and general health must be considered. Patients’ weight loss …

… (IPF) is a chronic, progressive interstitial lung disease that has no cure. Many … weight loss
in patients with IPF. However, factors associated with weight loss and the impact of weight loss …

… weight loss were reliable markers for predicting the mortality risk in IPF, which means that
improving BMI and weight loss … on the effect of BMI and weight loss on the prognosis in IPF. …

… The treatment of idiopathic pulmonary fibrosis (IPF) has been … and often necessitates dose
reduction or discontinuation [1,2]. Both … and thus can result in weight loss, an effect that can be …

… Significant weight loss was defined as a weight loss of \(\ge\) 5% over 1 year after diagnosis
… of patients with weight loss was shorter than that of those without weight loss (29.4 ± 2.3 vs. …

… Malnutrition in pulmonary fibrosis may influence clinical outcomes negatively. This
project aimed to investigate if weight, unintended weight loss (UWL) at baseline and weight …

… It is important to remember that changes in cytokine production observed with excess
weight are exerted by visceral fat. Visceral adiposity is not measured by BMI. Hence, what role …

… by voluntary dietary regulation and exercise, which is contrary to the weight loss in our IPF
population which was anecdotally observed in almost all cases to be unintended. Although …

… Nintedanib is approved for the treatment of idiopathic pulmonary fibrosis (IPF). Weight loss
is … In conclusion, weight loss is an important issue for the management of patients with IPF …